ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0977

Enhancement of Patient and Clinician Partnerships in Juvenile Idiopathic Arthritis Management Using a Point-of-Care Dashboard: Development and Pilot Testing

Erica Lawson1, Lisa Johnson2, Jabeen Ahmad2, Vincent Del Gaizo3, Brittany Donaldson4, Julie Eller5, Yukiko Kimura6, Cathy Knucken7, Tzielan Lee8, Corinne Pinter9, Doreen Tabussi10, Alysha Taxter11 and Aricca Van Citters2, 1University of California San Francisco, San Francisco, CA, 2Dartmouth College, Lebanon, NH, 3Childhood Arthritis & Rheumatology Research Alliance (CARRA), Whitehouse Station, NJ, 4Wake Forest University School of Medicine Brenner Children's, Winston Salem, NC, 5Arthritis Foundation, Washington, DC, 6Hackensack University Medical Center, New York, NY, 7Patient Partner, Byram, NJ, 8Stanford University School of Medicine, Palo Alto, CA, 9Patient Partner, Sugar Land, TX, 10Hackensack University Medical Center, Upper Saddle River, NJ, 11Wake Forest Baptist Medical Center, Winston-Salem, NC

Meeting: ACR Convergence 2021

Keywords: communications, education, patient, Juvenile idiopathic arthritis, Patient reported outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: Pediatric Rheumatology – Clinical (0974–0979)

Session Type: Abstract Session

Session Time: 2:45PM-3:00PM

Background/Purpose: Health outcomes improve when people living with chronic conditions partner with their clinicians to coproduce care based on their values, preferences, goals, and the best scientific evidence. Patient-facing dashboards can be used to support coproduction by aggregating longitudinal data for review during clinical encounters, such as patient-reported outcomes (PROs), clinical data, and medications. We developed and implemented a point-of-care dashboard to enhance collaboration between families of children with juvenile idiopathic arthritis (JIA) and their clinicians and care teams.

Methods: The dashboard was developed through a co-design process including patients, parents, clinicians, and care team members. Delphi voting achieved consensus on dashboard data elements. The dashboard leveraged an Epic electronic health record (EHR) tool that was customized and integrated at four medical centers. The dashboard resides within each site’s EHR and aggregates PROs and clinical data in real-time for review by the family and clinician together (Figure 1). A convenience sample of JIA patients and parents completed an anonymous 19-item feedback survey following their clinic visit to assess the utility and usability of the dashboard. A subset of patients and parents completed 30-minute interviews with the research team. Feedback from clinicians was collected during biweekly meetings, and via surveys and interviews. Data were collected between July 2020 and April 2021.

Results: During the development phase, end-users agreed that a dashboard needed to be easy to use and trend data over time. Data elements included: (1) PROs of pain interference, upper extremity function, mobility, patient questions/concerns, medication adherence, medication side effects; (2) clinical data including active joint count, disease activity score, and liver toxicity; and, (3) current and past medications (Table 1). There was some variability in implementation among sites due to factors such as programmer availability, workflow changes, and clinic staff. During the testing phase, 101 JIA families completed a post-visit feedback survey: 93% agree or strongly agree the dashboard was useful during discussions, 89% indicated that it helped to talk about what mattered most, and 81% reported that it helped to make healthcare decisions. The Net Promoter Score, which rated the likelihood of families to recommend the dashboard to a friend or peer, was a +68 ( >50 = excellent). Families valued the ability to share questions/concerns in advance of the visit, insight into clinical assessment data used by clinicians, and visualization of data over time to inform shared treatment decisions with their clinicians.

Conclusion: Building upon basic Epic functionality, we implemented a JIA dashboard at four sites, informed by a human-centered design approach with a diverse group of stakeholders. Data demonstrated that the dashboard effectively facilitates shared decision making between JIA families and their clinicians. Additional efforts are ongoing to spread the dashboard use to other clinicians and to determine optimal use of the dashboard during telehealth visits.

Figure 1. Pediatric Rheumatology Dashboard displaying longitudinal patient-reported and clinical data

Table 1. Recommended Data Elements for inclusion in the JIA Dashboard


Disclosures: E. Lawson, None; L. Johnson, None; J. Ahmad, None; V. Del Gaizo, CARRA, 3; B. Donaldson, None; J. Eller, None; Y. Kimura, Genentech, 5, UpToDate, 9, CARRA, 4, 12, Salary support; C. Knucken, None; T. Lee, None; C. Pinter, None; D. Tabussi, None; A. Taxter, None; A. Van Citters, None.

To cite this abstract in AMA style:

Lawson E, Johnson L, Ahmad J, Del Gaizo V, Donaldson B, Eller J, Kimura Y, Knucken C, Lee T, Pinter C, Tabussi D, Taxter A, Van Citters A. Enhancement of Patient and Clinician Partnerships in Juvenile Idiopathic Arthritis Management Using a Point-of-Care Dashboard: Development and Pilot Testing [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/enhancement-of-patient-and-clinician-partnerships-in-juvenile-idiopathic-arthritis-management-using-a-point-of-care-dashboard-development-and-pilot-testing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhancement-of-patient-and-clinician-partnerships-in-juvenile-idiopathic-arthritis-management-using-a-point-of-care-dashboard-development-and-pilot-testing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology